Daré Bioscience Dividendo
Dividendo criteri di controllo 0/6
Daré Bioscience does not have a record of paying a dividend.
Informazioni chiave
n/a
Rendimento del dividendo
-26.1%
Rendimento del riacquisto
Rendimento totale per gli azionisti | -26.1% |
Rendimento futuro dei dividendi | n/a |
Crescita dei dividendi | n/a |
Prossima data di pagamento dei dividendi | n/a |
Data di stacco del dividendo | n/a |
Dividendo per azione | n/a |
Rapporto di remunerazione | n/a |
Aggiornamenti recenti sui dividendi
Nessun aggiornamento
Recent updates
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate
Nov 07We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Jul 21Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?
Mar 12Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms
Oct 17Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive
Oct 10Dare Bioscience reports positive progress for cream for female sexual arousal disorder
Aug 29Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy
Jun 30Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?
Apr 02Diving Back Into Daré Bioscience Again
Jan 07We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Nov 26Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study
Apr 26Diving Into Daré Bioscience
Jan 31Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching
Dec 22Dare Bioscience EPS misses by $0.06
Nov 12Stabilità e crescita dei pagamenti
Recupero dei dati sui dividendi
Dividendo stabile: Insufficient data to determine if DARE's dividends per share have been stable in the past.
Dividendo in crescita: Insufficient data to determine if DARE's dividend payments have been increasing.
Rendimento dei dividendi rispetto al mercato
Daré Bioscience Rendimento dei dividendi rispetto al mercato |
---|
Segmento | Rendimento dei dividendi |
---|---|
Azienda (DARE) | n/a |
Fondo del 25% del mercato (US) | 1.5% |
Top 25% del mercato (US) | 4.5% |
Media del settore (Pharmaceuticals) | 2.3% |
Analista previsionale (DARE) (fino a 3 anni) | n/a |
Dividendo notevole: Unable to evaluate DARE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Dividendo elevato: Unable to evaluate DARE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Distribuzione degli utili agli azionisti
Copertura degli utili: Insufficient data to calculate DARE's payout ratio to determine if its dividend payments are covered by earnings.
Pagamenti in contanti agli azionisti
Copertura del flusso di cassa: Unable to calculate sustainability of dividends as DARE has not reported any payouts.